GlassScriptPhysician profile
Feno M Monaco
NPI 1104267830
$11,764.83
in general payments reported to CMS, 2019-2025
17 companies · $1,756 in 2025
The $1,756 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,287 · 2020: $1,553 · 2021: $1,941 · 2022: $1,365 · 2023: $1,829 · 2024: $1,033 · 2025: $1,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,618.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,199.75 | 2019-2025 | Proclaim, Eterna, Penta |
| Medtronic USA, INC. | $524.68 | 2019 | |
| Medtronic, INC. | $522.50 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Accurian |
| Si-Bone, INC. | $498.87 | 2019-2024 | |
| Tersera Therapeutics LLC | $148.69 | 2019-2020 | |
| Stryker Corporation | $134.11 | 2022 | |
| Relievant Medsystems, INC. | $130.66 | 2021 | |
| Siemens Medical Solutions USA, INC. | $121.96 | 2022 | |
| Mml US, INC. | $117.88 | 2023 | Reactiv8 |
| Scilex Pharmaceuticals INC. | $112.70 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $65.17 | 2023 | Belbuca, Xtampza |
| Boston Scientific Corporation | $61.19 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.51 | 2019 | |
| Biodelivery Sciences International, INC. | $27.65 | 2019-2020 | |
| Zyla Life Sciences, INC. | $16.62 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.89 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Feno Monaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.